Tao Zhang

• A Prospective, Biomarker-Stratified Phase 2 Study: β-Hydroxybutyrate as a Predictive Biomarker for Short-Course Radiotherapy Followed by Chemotherapy Plus PD-1 Inhibitor Versus Chemotherapy Alone in Locally Advanced Rectal Cancer

  Phase 2, Not yet recruiting, 144 people, 29 Sept 2026

• NCT07243938

  Phase 2, Not yet recruiting, 70 people, 24 Nov 2025

• NCT07239466

  Phase 2, Recruiting, 25 people, 20 Nov 2025

• NCT07113275

  Phase 3, Recruiting, 444 people, 8 Aug 2025

• NCT03170739

  Phase 4, Status unknown, 180 people, 31 May 2017

• NCT03149588

  Phase 4, Status unknown, 60 people, 11 May 2017

• NCT02509949

  Phase 4, Status unknown, 100 people, 28 Jul 2015

• NCT02107170

  Phase 4, Completed, 68 people, 8 Apr 2014

Sources: clinicaltrials.gov